Ultrasound could spot hidden fluid that sends heart patients back to hospital

NCT ID NCT07682298

Recruiting now Knowledge-focused Sponsor: Aarhus University Hospital Source: ClinicalTrials.gov ↗

First seen Jul 02, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study tests whether ultrasound scans can detect leftover fluid in the lungs and veins of people hospitalized for heart failure. About 580 adults will get scans at several points during their stay, but doctors won't see the results. Researchers will then track who is readmitted or dies within 90 days to see if the scans predict problems better than standard exams.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify which heart failure patients need more treatment before leaving the hospital, potentially reducing readmissions.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly improve outcomes. The ultrasound method may not prove better than standard checks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE HEART FAILURE (AHF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congestive heart failure heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE HEART FAILURE (AHF) DECOMPENSATED CHRONIC HEART FAILURE

Contacts and locations

Locations

Aarhus University Hospital - Department of Cardiology
RECRUITING

Aarhus, 8200, Denmark
Copenhagen University Hospital, Amager and Hvidovre Hospital - Department of Cardiology
NOT_YET_RECRUITING

Copenhagen, 2650, Denmark
Zealand University Hospital - Department of Cardiology
NOT_YET_RECRUITING

Roskilde, 400, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.